Sean OReilly, who teaches history and economics at Sharon High School, said his health has improved dramatically since his doctor prescribed Wegovy, a GLP-1, last June for weight loss
The success of these clinical trials has led to widespread approval of semaglutide for weight management, offering a promising and effective option for individuals struggling with obesity and related health conditions
[12] [13] While these mechanisms contribute to improved glycemic control and weight loss, they also explain why gastrointestinal side effects are among the most commonly reported adverse reactions
Care has been taken to ensure accuracy, though readers are advised to verify key details from reliable sources
Meanwhile, Novo is in a battle to acquire the obesity drug developer Metsera, offering as much as $9 billion to counter a competing bid from Pfizer
Loss of iron in women can be especially detrimental to hair growth